-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
The -X- _ O
pathways -X- _ O
and -X- _ O
mechanism -X- _ O
by -X- _ O
which -X- _ O
associations -X- _ O
between -X- _ O
the -X- _ O
gut -X- _ O
microbiome -X- _ O
and -X- _ O
the -X- _ O
brain -X- _ O
, -X- _ O
termed -X- _ O
the -X- _ O
microbiome-gut-brain -X- _ B-Patient
axis -X- _ I-Patient
( -X- _ I-Patient
MGBA -X- _ I-Patient
) -X- _ I-Patient
, -X- _ O
are -X- _ O
manifest -X- _ O
but -X- _ O
remain -X- _ O
to -X- _ O
be -X- _ O
fully -X- _ O
elucidated. -X- _ O
This -X- _ O
study -X- _ O
aims -X- _ O
to -X- _ O
use -X- _ O
bibliometric -X- _ B-Intervention
analysis -X- _ I-Intervention
to -X- _ O
estimate -X- _ O
the -X- _ O
global -X- _ O
activity -X- _ O
within -X- _ O
this -X- _ O
rapidly -X- _ O
developing -X- _ O
field -X- _ O
and -X- _ O
to -X- _ O
identify -X- _ O
particular -X- _ O
areas -X- _ O
of -X- _ O
focus -X- _ O
that -X- _ O
are -X- _ O
of -X- _ O
current -X- _ O
relevance -X- _ O
to -X- _ O
the -X- _ O
MGBA -X- _ B-Patient
during -X- _ O
the -X- _ O
last -X- _ O
decade -X- _ O
( -X- _ O
2009–2018 -X- _ O
) -X- _ O
. -X- _ O
METHODS -X- _ O
: -X- _ O
The -X- _ O
current -X- _ O
study -X- _ O
uses -X- _ O
the -X- _ O
Scopus -X- _ O
for -X- _ O
data -X- _ O
collection. -X- _ O
We -X- _ O
used -X- _ O
the -X- _ O
key -X- _ O
terms -X- _ O
“microbiome-gut-brain -X- _ B-Patient
axis” -X- _ I-Patient
and -X- _ O
its -X- _ O
synonyms -X- _ O
because -X- _ O
we -X- _ O
are -X- _ O
concerned -X- _ O
with -X- _ O
MGBA -X- _ O
per -X- _ O
se -X- _ O
as -X- _ O
a -X- _ O
new -X- _ O
concept -X- _ O
in -X- _ O
research -X- _ O
rather -X- _ O
than -X- _ O
related -X- _ O
topics. -X- _ O
A -X- _ O
VOSviewer -X- _ O
version -X- _ O
1.6.11 -X- _ O
was -X- _ O
used -X- _ O
to -X- _ O
visualize -X- _ O
collaboration -X- _ O
pattern -X- _ O
between -X- _ O
countries -X- _ O
and -X- _ O
authors -X- _ O
, -X- _ O
and -X- _ O
evolving -X- _ O
research -X- _ O
topics -X- _ O
by -X- _ O
analysis -X- _ O
of -X- _ O
the -X- _ O
term -X- _ O
cooccurrence -X- _ O
in -X- _ O
the -X- _ O
title -X- _ O
and -X- _ O
abstract -X- _ O
of -X- _ O
publications. -X- _ O
RESULTS -X- _ O
: -X- _ O
Between -X- _ B-Outcome
2009 -X- _ I-Outcome
and -X- _ I-Outcome
2018 -X- _ I-Outcome
, -X- _ I-Outcome
there -X- _ I-Outcome
were -X- _ I-Outcome
51,504 -X- _ I-Outcome
published -X- _ I-Outcome
documents -X- _ I-Outcome
related -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
microbiome -X- _ I-Outcome
, -X- _ I-Outcome
including -X- _ I-Outcome
1713 -X- _ I-Outcome
articles -X- _ I-Outcome
related -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
MGBA -X- _ I-Outcome
: -X- _ I-Outcome
829 -X- _ I-Outcome
( -X- _ I-Outcome
48.4 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
original -X- _ I-Outcome
articles -X- _ I-Outcome
, -X- _ I-Outcome
658 -X- _ I-Outcome
( -X- _ I-Outcome
38.4 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
reviews -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
226 -X- _ I-Outcome
( -X- _ I-Outcome
13.2 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
other -X- _ I-Outcome
articles -X- _ I-Outcome
such -X- _ I-Outcome
as -X- _ I-Outcome
notes -X- _ I-Outcome
, -X- _ I-Outcome
editorials -X- _ I-Outcome
or -X- _ I-Outcome
letters. -X- _ I-Outcome
The -X- _ I-Outcome
USA -X- _ I-Outcome
took -X- _ I-Outcome
the -X- _ I-Outcome
first -X- _ I-Outcome
place -X- _ I-Outcome
with -X- _ I-Outcome
385 -X- _ I-Outcome
appearances -X- _ I-Outcome
, -X- _ I-Outcome
followed -X- _ I-Outcome
by -X- _ I-Outcome
Ireland -X- _ I-Outcome
( -X- _ I-Outcome
n -X- _ I-Outcome
= -X- _ I-Outcome
161 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
China -X- _ I-Outcome
( -X- _ I-Outcome
n -X- _ I-Outcome
= -X- _ I-Outcome
155 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
Canada -X- _ I-Outcome
( -X- _ I-Outcome
n -X- _ I-Outcome
= -X- _ I-Outcome
144 -X- _ I-Outcome
) -X- _ I-Outcome
.The -X- _ I-Outcome
overall -X- _ I-Outcome
citation -X- _ I-Outcome
h-index -X- _ I-Outcome
was -X- _ I-Outcome
106 -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
the -X- _ I-Outcome
countries -X- _ I-Outcome
with -X- _ I-Outcome
the -X- _ I-Outcome
highest -X- _ I-Outcome
h-index -X- _ I-Outcome
values -X- _ I-Outcome
were -X- _ I-Outcome
the -X- _ I-Outcome
USA -X- _ I-Outcome
( -X- _ I-Outcome
69 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
Ireland -X- _ I-Outcome
( -X- _ I-Outcome
58 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
Canada -X- _ I-Outcome
( -X- _ I-Outcome
43 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
The -X- _ I-Outcome
cluster -X- _ I-Outcome
analysis -X- _ I-Outcome
demonstrated -X- _ I-Outcome
that -X- _ I-Outcome
the -X- _ I-Outcome
dominant -X- _ I-Outcome
fields -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
MGBA -X- _ I-Outcome
include -X- _ I-Outcome
four -X- _ I-Outcome
clusters -X- _ I-Outcome
with -X- _ I-Outcome
four -X- _ I-Outcome
research -X- _ I-Outcome
directions -X- _ I-Outcome
: -X- _ I-Outcome
“modeling -X- _ I-Outcome
MGBA -X- _ I-Outcome
in -X- _ I-Outcome
animal -X- _ I-Outcome
systems” -X- _ I-Outcome
, -X- _ I-Outcome
“interplay -X- _ I-Outcome
between -X- _ I-Outcome
the -X- _ I-Outcome
gut -X- _ I-Outcome
microbiota -X- _ I-Outcome
and -X- _ I-Outcome
the -X- _ I-Outcome
immune -X- _ I-Outcome
system” -X- _ I-Outcome
, -X- _ I-Outcome
“irritable -X- _ I-Outcome
bowel -X- _ I-Outcome
syndrome -X- _ I-Outcome
related -X- _ I-Outcome
to -X- _ I-Outcome
gut -X- _ I-Outcome
microbiota” -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
“neurodegenerative -X- _ I-Outcome
diseases -X- _ I-Outcome
related -X- _ I-Outcome
to -X- _ I-Outcome
gut -X- _ I-Outcome
microbiota”. -X- _ I-Outcome
CONCLUSIONS -X- _ O
: -X- _ O
This -X- _ O
study -X- _ O
demonstrates -X- _ O
that -X- _ O
the -X- _ O
research -X- _ O
on -X- _ O
the -X- _ O
MGBA -X- _ O
has -X- _ O
been -X- _ O
becoming -X- _ O
progressively -X- _ O
more -X- _ O
extensive -X- _ O
at -X- _ O
global -X- _ O
level -X- _ O
over -X- _ O
the -X- _ O
past -X- _ O
10 -X- _ O
years. -X- _ O
Overall -X- _ O
, -X- _ O
our -X- _ O
study -X- _ O
found -X- _ O
that -X- _ O
a -X- _ O
large -X- _ O
amount -X- _ O
of -X- _ O
work -X- _ O
on -X- _ O
MGBA -X- _ O
focused -X- _ O
on -X- _ O
immunomodulation -X- _ O
, -X- _ O
irritable -X- _ O
bowel -X- _ O
syndrome -X- _ O
, -X- _ O
and -X- _ O
neurodevelopmental -X- _ O
disorders. -X- _ O
Despite -X- _ O
considerable -X- _ O
progress -X- _ O
illustrating -X- _ O
the -X- _ O
communication -X- _ O
between -X- _ O
the -X- _ O
gut -X- _ O
microbiome -X- _ O
and -X- _ O
the -X- _ O
brain -X- _ O
over -X- _ O
the -X- _ O
past -X- _ O
10 -X- _ O
years -X- _ O
, -X- _ O
many -X- _ O
issues -X- _ O
remain -X- _ O
about -X- _ O
their -X- _ O
relevance -X- _ O
for -X- _ O
therapeutic -X- _ O
intervention -X- _ O
of -X- _ O
many -X- _ O
diseases -X- _ O
. -X- _ O

